About Fred Hutch Lung Cancer Program
The Fred Hutch Lung Cancer Program is committed to bringing novel adoptive cellular therapies to lung cancer patients. While these therapies, which recruit the body’s immune system to fight cancer, have shown promise in treating blood cancers like lymphoma and leukemia, their effectiveness in solid cancers, such as lung cancer, has been limited.
Lung SPORE Team Research
The Lung SPORE team is pioneering a novel vaccine strategy that involves engineering T cells outside the body and reintroducing them into patients — an innovative approach with the potential to revolutionize cancer vaccine research. Research like this is core to Fred Hutch’s mission, as is addressing the complex physical, psychological, and practical challenges that patients face.
William E. Wockner Foundation's Impact
Cancer can upend a patient’s life by adding significant financial strain. Many families struggle with basic household expenses and relocation costs associated with traveling for treatment. The Patient and Family Assistance Fund provides crucial financial support to patients and their families, helping them pay for basic needs like lodging, food, and transportation. This ensures that patients can access the care they need and focus on their health without worrying about financial stresses above and beyond their treatment. In 2024, funds from the William E. Wockner Foundation helped approximately 30 patients and their families pay for food, transportation, and lodging.
30
Families Given Financial Assistance
51 %
Funds Allocated to food assistance
39 %
Funds Allocated to lodging
6 %